ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Anti-CD62L Antibody [Mel-14] - Low endotoxin, Azide free (A85752)

This product is discontinued

Anti-CD62L Antibody [Mel-14] - Low endotoxin, Azide free (A85752) has been discontinued and is no longer available.

View all CD62L Antibodies.

Name
Anti-CD62L Antibody [Mel-14] - Low endotoxin, Azide free
Description
Rat monoclonal [Mel-14] antibody to CD62L.
Specificity
This antibody MEL-14 reacts with mouse CD62L (L-selectin), a 75 kDa single chain type I glycoprotein expressed on most peripheral blood B lymphocytes, T lymphocytes, monocytes and granulocytes; it is also present on a subset of NK cells and certain hematopoietic malignant cells.
Applications
Flow Cytometry, IP, IHC-P, IHC-Fr, ICC, Functional Studies
Dilutions
FUNC: Blocking of cell adhesion, Flow Cytometry: 1-4 µg/ml.
Reactivity
Mouse
Immunogen
C3H/eb mouse B cell lymphoma 38C-13.
Host
Rat
Clonality
Monoclonal
Clone ID
Mel-14
Isotype
IgG2a
Conjugate

Unconjugated

Purification
Protein G chromatography.
Concentration
1 mg/ml
Predicted MW
75 kDa
Product Form
Liquid
Formulation
Supplied in Phosphate Buffered Saline, pH 7.4, without Sodium Azide (0.2 µm filter sterilized). Endotoxin level is less than 0.01 EU/µg of the protein.
Storage
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze/thaw cycles.
Synonyms
CD62 antigen-like family member L, L-selectin, LAM-1, LECAM1, Leukocyte adhesion molecule 1, Leukocyte surface antigen Leu-8, Leukocyte-endothelial cell adhesion molecule 1, LNHR, LYAM1, Lymph node homing receptor, SELL
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.

Alternative products to Anti-CD62L Antibody [Mel-14] - Low endotoxin, Azide free (A85752)

Proteins predicted to interact with CD62L

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.9% Relevancy Score
99.9% Relevancy Score
99.8% Relevancy Score
99.8% Relevancy Score
99.5% Relevancy Score
98.8% Relevancy Score
98.6% Relevancy Score
97.6% Relevancy Score
97% Relevancy Score